Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Before this study, no one had directly tested what happens when you feed a raw versus cooked diet to animal models or humans.
Surprising new research suggests why 97% of cancer drugs in clinical trials fail to stop cancer in patients and never make it to market.
At her lowest ebb, breast cancer survivor Amanda Enayati, our cover subject, discovered serenity.
Yung S. Lie, PhD, is the president and CEO of the Damon Runyon Cancer Research Foundation.
Yung S. Lie, PhD, sat down with Denver Frederick, host of “The Business of Giving,” to discuss the history and strategy of the organizatio...
How one foundation keeps funding cancer breakthroughs
The latest research on healthy life and prevention, improving outcomes, reducing side effects and getting the best precision medicine.
Betting on basic science is leading to breakthroughs in immune checkpoint inhibitors, CAR-T, targeted therapies, cancer vaccines and more.
The approach to finding and funding “brave and bold” new ideas goes back to 1946.
An interview with Yung S. Lie, PhD, president and CEO of the Damon Runyon Cancer Research Foundation
People with severe Gorlin Syndrome may have as many as 30 surgeries per year.
“We have reason to hope that the basic principle could help glioblastoma patients. The next step is to work on a clinical trial to test it.”
Grants totaling nearly $3.5 million give early career investigators independence to pursue brave and bold cancer research.
“The history of Damon Runyon exemplifies fantastic scientists who have gone on to do amazing things,” says Bruce W. Stillman, PhD.
The program is intended to address the shortage of physicians capable of translating scientific discovery into new cancer breakthroughs.
The award is for her work “identifying the novel chemistry of the gut microbiome and deciphering its role in human health and disease.”
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.